CROs/Service Providers

The changing landscape of clinical trials in Asia and the Pacific Rim

Tuesday, December 1, 2015

In recent years, the clinical trial landscape in Asia and the Pacific Rim has evolved faster than in most other regions. More than half of the world’s population lives in this rapidly developing area, which includes advanced economies such as Australia, Singapore and South Korea, as well as countries with vast populations like India and China.

[Read More]

PharmaSeek launches oncology-based business

Monday, November 23, 2015

PharmaSeek has launched a new business called The Oncology Hub, an initiative to bring together sponsors, CROs, academic research institutions, major medical centers, oncology networks and stand-alone oncology sites in order to assist with site identification for complex clinical trials.

[Read More]

Thermo Fisher Scientific opens facility in Singapore

Friday, November 20, 2015

Thermo Fisher Scientific has opened a new state-of-the-art GMP facility in Singapore. The company, which established its first clinical services facility there in 2001, said the move to the newly built facility will meet the growing demand for clinical supply services in the region. The new site will provide both regional and global pharmaceutical and biotech companies with a one-stop service for clinical supplies—from GMP storage, local labeling, secondary packaging, comparator sourcing, handling and distribution of ambient and cold chain supplies to returns management.

[Read More]

IMARC expands service offerings

Wednesday, November 18, 2015

IMARC Research, a Strongsville, Ohio-based CRO, has launched independent oversight capabilities by adding Data Safety Monitoring Boards (DSMBs) and Clinical Events Committees (CECs) to its existing monitoring, auditing, training, project management and consulting services.

[Read More]

Parexel enhances clinical development services

Wednesday, November 18, 2015

Parexel International, a global biopharmaceutical services provider, has enhanced its end-to-end clinical development services through a new process called Clinical Development Optimization. The Parexel Clinical Development Optimization process uses advanced technology to help expedite drug development through all four critical stages of clinical development—design, startup, trial execution and submission.

[Read More]